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Abstract 
The okaramine indole alkaloids were recently shown to be more selective than 
ivermectin in activating the glutamate-gated chloride channels of the silkworm larvae of 
Bombyx mori (BmGluCls). Those studies were carried out using the exon 3b variant as a 
representative of BmGluCls. However, it remains unknown whether okaramines are 
similarly effective on other silkworm GluCl variants and whether they share the same 
binding site as ivermectin on GluCls. To begin to address these questions, we examined 
the potency of four okaramines on the exon 3c variant of BmGluCls by two-electrode 
voltage clamp voltage recordings of glutamate-induced chloride currents. The potency 
of okaramines in activating the exon 3c BmGluCl agreed well with findings on the exon 
3b BmGluCl and insecticidal potency. Okaramine B (10 μM) reduced the maximum 
binding (Bmax) but not the dissociation constant (KD) of [
3H]ivermectin in studies on 
plasma membrane fractions of HEK293 cells expressing the exon 3c variant. These 
findings indicate that activation of GluCls is important in the insecticidal actions of 
okaramines.      
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Introduction 
Okaramines (Fig. 1) are prenylated indole alkaloids produced by the molds 
Penicillium simplicissimum AK-40 and Aspergillus aculeatus. The first two compounds, 
okaramines A and B, were isolated as insecticidal compounds from the okara medium 
fermented by P. simplicissimum and tested by oral application to larvae of the silkworm 
Bombyx mori (Hayashi et al., 1989). Thereafter, a quest for other okaramines from these 
fungal metabolites led to the discovery of 16 more compounds (Hayashi, 2015). Of all 
the okaramine family, okaramine B was the most potent in insect toxicity tests and its 
potent action was shown to be dependent on the presence of azocine and azetidine rings 
(Hayashi, 2015, Shiono et al., 2000a).  
Okaramines paralyze silkworm larvae within a few hours following their 
application by injection, indicating a possible action on the nervous system (Furutani et 
al., 2014b). We have employed the whole-cell patch-clamp technique to investigate their 
actions and found that okaramines induced chloride currents in the silkworm larval 
neurons. We went on to test these alkaloids on a Bombyx γ-aminobutyric acid 
(GABA)-gated chloride channel (BmRDL), which is a homologue of the exon 3b/exon 
6d variant of the Drosophila RDL GABA receptor (ffrench-Constant and Rocheleau, 
1993), as well as the exon 3b variant of glutamate-gated chloride channels (GluCls) 
(Furutani et al., 2014a). Neither agonist, nor antagonist actions of okaramines were 
observed on expressed BmRDL (Furutani et al., 2014b). By contrast, the Bombyx mori 
GluCl (BmGluCl) was activated in a concentration-dependent manner by okaramines 
with their relative potency showing correlations with their insecticidal actions on 
silkworm larvae (Furutani et al., 2014b). A similar order of potency was observed in 
GluCl studies on native Bombyx mori neurons, pointing to GluCl as a primary target of 
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okaramines (Furutani et al., 2014b). However, we did not test the okaramines on the 
exon 3c variant of BmGluCl although it is expressed at a level similar to that of the 3b 
variant in the brain and 3rd thoracic ganglion of Bombyx mori (Furutani et al., 2014a). 
Thus, it is important to address whether okaramines act on the exon 3c variant and the 
exon 3b variant with similar potency, thereby implicating both variants in the 
insecticidal activity of these natural products on the silkworm larvae. 
Like okaramines, the macrolide compound ivermectin also modulates GluCls, 
inducing persistent chloride currents when measured by voltage clamp 
electrophysiology (Furutani et al., 2014a, Raymond and Sattelle, 2002, Wolstenholme 
and Kaplan, 2012, Wolstenholme and Rogers, 2005). Co-crystallisation studies show 
that ivermectin interacts with the allosteric site formed by transmembrane regions 
(TMs) and a TM2-TM3 linker in the Caenorhabditis elegans GluCl (Hibbs and Gouaux, 
2011). It remains to be determined if okaramines interact with GluCl in a manner 
similar to that of ivermectin.  
To begin to address the roles of exon 3 variants and whether okaramines and 
ivermectin act in the same way, we have investigated 1) the actions of four okaramines 
(A, B, 4’,5’-dihydrookaramine B (Okaramine B-H2) and Q) on the exon 3c variant of 
BmGluCls expressed in Xenopus oocytes by using two-electrode voltage clamp 
electrophysiology, and 2) the effects of okaramine B on the binding of [3H] ivermectin 
to membrane preparations including the exon 3c variant.  
 
Materials and Methods.  
Chemicals.  
Okaramines A, B and Q were obtained from the okara media fermented by P. 
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simplicissimum AK-40 (Hayashi et al., 1989, Shiono et al., 2000b), while okaramine 
B-H2 was prepared by partial reduction of okaramine B (Shiono et al., 2000a). 
Ivermectin and L-glutamate were purchased from Sigma Aldrich (St. Louis, MO, USA), 
while [3H]ivermectin (50 Ci/mmol) was purchased from American Radiolabeled 
Chemicals, Inc. (St. Louis, MO, USA).  
 
cRNA preparation.  
cDNAs of exon 3b (Accession number; KC342244) and 3c (Accession number: 
KC342245) variants of BmGluCls cloned into the pcDNA3.1 (+) vector (Thermo Fisher 
Scientific, Waltham, MA USA) were used for preparation of cRNAs. The cRNA was 
prepared by in vitro transcription using the mMESSAGE mMACHINE T7 ULTRA kit 
(Life Technologies, CA, USA) from the linearized cDNA according to the kit manual. 
cRNA was dissolved in RNase-free water at 1 mg ml-1 and stored at -80ºC until use. 
 
Functional expression of BmGluCl variants in Xenopus laevis oocytes. 
Excised varies of Xenopus laevis were treated with 2.0 mg ml1 collagenase (Type 
IA, Sigma-Aldrich) in the Ca2-free standard oocyte saline (SOS) containing 100 mM 
NaCl, 2 mM KCl, 1 mM MgCl2 and 5 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 5.0 (pH 7.6 adjusted with 
NaOH), and then transferred into SOS (100 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 
mM MgCl2 and 5 mM HEPES (pH 7.6)) (Ihara et al., 2003, Matsuda et al., 1998, 
Shimomura et al., 2002, Shimomura et al., 2006). Each oocyte was injected with 50 nl 
of the cRNA solution and incubated for 1 day at 16C in SOS supplemented with 
penicillin (100 units ml1), streptomycin (100 μg ml1), gentamycin (20 μg ml1) and 2.5 
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mM sodium pyruvate prior to conducting electrophysiology experiments. 
 
Voltage-clamp electrophysiology 
The two-electrode voltage-clamp electrophysiology was conducted at 18 – 23C. 
The Xenopus oocytes were perfused with SOS at a flow rate of 7 – 10 ml min1 (Ihara et 
al., 2003, Shimomura et al., 2002, Shimomura et al., 2006). Membrane currents were 
recorded using a Geneclamp 500B amplifier (Molecular Devices, Sunnyvale, CA, USA) 
at -80 mV. The electrodes were filled with 2 M KCl and had a resistance of 1 – 5 MΩ. 
Signals were digitized by a Digidata 1200 (Molecular Devices) and recorded by 
Clampex 8 (Molecular Devices). L-Glutamate was directly dissolved in SOS, whereas 
okaramine solution was prepared by diluting the 10 mM stock solution in dimethyl 
sulfoxide with SOS. Test solutions were applied to oocytes for 3 – 5 s with a 3–5 min 
interval (Furutani et al., 2014a, Furutani et al., 2014b).  
 
Data analysis 
Peak current amplitude of each okaramine response was measured by Clampfit 9 
(Molecular Devices) and normalized to that of the L-glutamate response at 100 μM, a 
submaximal concentration where no GluCl desensitization was observed. The 
concentration-response curves for the okaramine-induced response of BmGluCl were 
fitted according to the following equation using Prism 4 (GraphPad Software, CA, 
USA): 
50 H(logEC -[A])n
Imax
Y =
1+10
  
where Y is the normalized response to okaramines at a concentration of A, Imax is the 
maximal normalized response, EC50 (M) is the half maximal effective concentration, 
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[A] is the logarithm of the concentration and nH is the Hill coefficient.   
 
Binding assay 
Binding experiments using [3H]ivermectin were conducted as previously 
described (Furutani et al., 2014a). The HEK293 cells were transfected with the 
BmGluCl exon 3b or exon 3c variant cDNA in the pcDNA 3.1 (+) vector and collected 
48 h after transfection. Cells were homogenized in 50 mM HEPES buffer (pH 7.4) 
supplemented with cOmplete protease inhibitor cocktail (F. Hoffmann-La Roche, Basel, 
Switzerland) and homogenates were centrifuged at 1,000 x g for 10 min. The 
supernatants were centrifuged at 25,000 x g for 30 min and resulting pellets were 
resuspended in 50 mM HEPES buffer (pH 7.4) for binding assays. Aliquots of such 
membrane preparations containing10 μg protein were incubated with 1 nM 
[3H]ivermectin in the absence and presence of test ligands, including okaramines, in 500 
μL of 50 mM HEPES buffer (pH 7.4) containing 0.02% Triton X-100 at 22°C for 60 
min. Candidate ligands were incubated for 10 min prior to application of [3H]ivermectin. 
Also, concentration-[3H]ivermectin binding relations for the membrane preparations 
containing the exon 3c variant were measured in the absence and presence of 10 μM 
okaramine B. Reactions were terminated by filtration through GF/B glass fiber filters 
(GE Healthcare Life Sciences, Uppsala, Sweden) using the M-24 cell harvester (Brandel, 
MD, USA). The filters were washed with cold distilled water containing 0.25% Triton 
X-100. The filter radioactivity was measured using the LSC-5100 liquid scintillation 
counter (Hitachi (formerly Aloka), Tokyo, Japan). In all experiments, specific binding 
fractions were obtained by subtracting a non-specific binding observed in the presence 
of 1 μM cold ivermectin from the total [3H]ivermectin binding. 
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Results 
1. Effects of exon 3 variation on GluCl activating potency of okaramines. 
Okaramines A, B, B-H2 and Q induced inward currents (Fig. 2A) in Xenopus 
oocytes expressing exon 3c variant of BmGluCl. The peak current amplitude of each 
response was normalized to that induced by 100 μM L-glutamate and plotted against 
okaramine concentrations (Fig. 2B). The concentration-normalized okaramine-induced 
response relationships were fitted by non-linear regression to determine pEC50 (= -log 
EC50 (M)) values (Table 1). The higher the pEC50 value, the higher is the 
GluCl-activating potency, and thus a rank of the GluCl-activating potency was 
okaramine B > B-H2 > A > Q.  
The pEC50 values of okaramines on exon 3c showed a good correlation with those 
reported on exon 3b with a correlation coefficient r2 of 0.90 (Fig. 3A). Also, the exon 3c 
activating potency also correlated with the insecticidal potency on Bombyx larvae in 
pLD50 with a correlation coefficient r
2 of 0.95 (Fig. 3B). 
 
2. Effects of okaramine B and ivermectin on [3H]ivermectin binding to exon 3c variant 
of GluCl expressed in HEK293 cells 
To examine whether okaramine B interacts with the ivermectin binding site in 
GluCl, we investigated the effects of 10 μM okaramine B on total binding of 1 nM 
[3H]ivermectin on the membrane fractions prepared from the HEK293 cells expressing 
the exon 3b and exon 3c variants. [3H]Ivermectin showed a significant binding activity 
on membrane preparations from HEK293 cells expressing exon 3c as well as exon 3b as 
previously observed (Fig. 4A). Unlabeled ivermectin (1 μM) markedly reduced the total 
1 nM [3H] ivermectin binding to both variants, leaving a non-specific binding fraction 
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(Fig. 4A). On the other hand, 10 μM okaramine B reduced the total 1 nM 
[3H]ivermectin binding to exon 3b and 3c by 10% and 16%, respectively (Fig. 4A).  
[3H]Ivermectin binding to the exon 3c variant was investigated in the presence 
and absence of 10 μM okaramine B (n = 3, Fig. 4B). Okaramine B significantly reduced 
the specific maximum binding (Bmax) of [3H]ivermectin from 8.68 ± 0.19 pmol/mg 
protein to 7.34 ± 0.29 pmol/mg protein (t-test, p < 0.05), whereas it had no significant 
effect on the dissociation constant KD (- okaramine B, 0.390 ± 0.026 nM: +10 μM 
okaramine B, 0.282 ± 0.037 nM) (Fig. 4B). 
 
Discussion 
We have previously investigated the effects of okaramines on the exon 3b variant 
in a study of the mode of insecticidal action of okaramines in Bombyx mori larvae. 
However, the exon 3c variant also expressed abundantly in the silkworm brain and 3rd 
thoracic ganglion (Furutani et al., 2014a), and forms a robust functional GluCl when 
expressed in Xenopus oocyte and HEK293 cells. Thus, it was important to test the same 
set of okaramines on the exon 3c variant to better understand the mode of action of 
these natural products. 
Replacing exon 3b by 3c had a minimum effect on the GluCl activating potency 
of the okaramines measured by EC50 values (Figure 3). This implies that residues that 
differ in 3c and 3b (Furutani et al., 2014a) are not part of the okaramine binding site in 
GluCl. The okaramine potency on exon 3c showed a correlation with the insecticidal 
potency (Fig. 3B), suggesting that both exon 3b and 3c variants play important roles in 
determining the insecticidal action on Bombyx mori larvae. 
The presence of 10 μM okaramine B had a significant but low impact on the 
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[3H]ivermectin binding to the exon 3c variant (Fig. 4A, B), whereas its effect on KD was 
minimal (Fig. 4B), pointing to a binding site for okaramines on GluCls distinct from 
that of ivermectin. However, appropriate caution is needed in the interpretation of the 
binding data because the experimental conditions were best tuned for detecting specific 
binding of [3H]ivermectin. Thus, the effects of mutations at the ivermectin binding site 
on the GluCl activating action of okaramines should be explored to test further the 
hypothesis that okaramine binds to a novel site on GluCls. In addition to such binding 
site discussion on GluCl, more studies are required to examine if okaramines have some 
effects on other ion channels that are targeted by pesticides.  
In conclusion, we have shown that okaramines act on the exon 3c variant of 
Bombyx GluCl expressed in Xenopus oocytes in a manner similar to their actions on the 
exon 3b variant. Hence both variants appear to contribute to the insecticidal actions of 
these molecules. We also demonstrated that okaramine B does not displace 
[3H]ivermectin binding to GluCls. It is conceivable that okaramines interact with a 
distinct site from ivermectin but further studies are needed to test this hypothesis. 
Okaramines are more selective than ivermectin on GluCls. It is therefore of importance 
to clarify the mechanism of selectivity and to test them on a broader range of pesticide 
targets. They may serve as new leads, which could be useful in the design of novel, 
safer compounds for the control of pest insect species. Understanding the basis of 
selective toxicity was a field pioneered by Professor Toshio Narahashi (Narahashi et al., 
2007, Narahashi et al., 2010). 
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Table 1. GluCl-activating potency of okaramines A, B, B-H2 and Q  
Compounds 
Exon 3ca Exon 3bb Insecticidal potencyb 
pEC50 pEC50 pLD50 
Okaramine A 5.32 ± 0.14 5.51 9.29 
Okaramine B 6.18 ± 0.14  6.11 10.81 
Okaramine B-H2 5.43 ± 0.30 5.64 9.85 
Okaramine Q 4.93 ± 0.13 4.81 8.40 
a. Each data represents mean ± standard error of the mean (n = 4). 
b. Data are from Furutani et al., 2014b. 
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Figure legends 
Figure 1. Structures of okaramines A, B, 4’5’-dihydrookaramine B (okaramine B-H2) 
and okaramine Q tested in this study. 
 
Figure 2. Okaramine-induced currents in Xenopus laevis oocytes expressing the exon 3c 
variant of BmGluCl (A) and concentration-response curves for 4 okaramines on GluCls 
(B). In B, the data are expressed as normalized responses relative to the peak current 
amplitude of the response to 100 μM L-glutamate. Each plot represents mean ± standard 
error of the mean (n = 4). 
 
Figure 3. Correlation of BmGluCl exon 3c variant activating potency with BmGluCl 
exon 3b variant activating potency (A) and insecticidal potency (B). Data for the 
potency on exon 3b variant and the silkworm larvae are taken from (Furutani et al., 
2014b). 
 
Figure 4. The effects of okaramine B and ivermectin on [3H]ivermectin binding to 
membrane fractions from HEK293 cell expressing BmGluCls. Each bar graph 
represents mean ± standard error of the mean (n = 3). A, Effects of 10 μM ivermectin 
and 10 μM okaramine B on total binding of 1 nM [3H]ivermectin. B, Relationships 
between concentration and specific binding of [3H]ivermectin to membrane fractions 
prepared from HEK293 cells expressing the exon 3c variant of BmGluCl in the absence 
and presence of 10 μM okarmine B. Each bar in A and plot in B represents the mean ± 
standard error of the mean (n = 3). Okaramine B significantly reduced Bmax (t-test, p < 
0.05), while hardly affecting KD of [
3H]ivermectin (See text for values).  
